ALLMedicine Hyperkalemia Center

May 26th, 2020 - Objective: To estimate the prevalence and economic burden of hyperkalemia in the United States (US) Medicare population.Methods: Patients were selected from a 5% random sample of Medicare beneficiaries (01/01/2010-12/31/2014) to estimate the preva...

May 26th, 2020 - DAX1 mutations are related to the X-linked form of adrenal hypoplasia congenita (AHC) in infancy and to hypogonadotropic hypogonadism (HH) in puberty. We report a male patient affected by X-linked AHC who presented with central diabetes insipidus ...

May 26th, 2020 - Medication Summary Usually, medications employed in the management of uremia are indicated for associated metabolic and electrolyte abnormalities, such as anemia, hyperkalemia, hypocalcemia, hyperparathyroidism, and iron deficiency. Agents used in...

May 22nd, 2020 - Hyperkalemia is a frequent and sometimes life-threatening condition that may be associated with arrhythmia and cardiac dysfunction in patients with heart failure (HF). High potassium levels in HF represent both a direct risk for cardiovascular com...

May 19th, 2020 - Significant deviations of serum potassium and sodium levels are frequently observed in hospitalized patients and are both associated with increased all-cause and cardiovascular mortality. The presence of acute or chronic renal failure facilitates ...

May 26th, 2020 - Objective: To estimate the prevalence and economic burden of hyperkalemia in the United States (US) Medicare population.Methods: Patients were selected from a 5% random sample of Medicare beneficiaries (01/01/2010-12/31/2014) to estimate the preva...

May 26th, 2020 - DAX1 mutations are related to the X-linked form of adrenal hypoplasia congenita (AHC) in infancy and to hypogonadotropic hypogonadism (HH) in puberty. We report a male patient affected by X-linked AHC who presented with central diabetes insipidus ...

May 26th, 2020 - Medication Summary Usually, medications employed in the management of uremia are indicated for associated metabolic and electrolyte abnormalities, such as anemia, hyperkalemia, hypocalcemia, hyperparathyroidism, and iron deficiency. Agents used in...

May 22nd, 2020 - Hyperkalemia is a frequent and sometimes life-threatening condition that may be associated with arrhythmia and cardiac dysfunction in patients with heart failure (HF). High potassium levels in HF represent both a direct risk for cardiovascular com...

May 19th, 2020 - Significant deviations of serum potassium and sodium levels are frequently observed in hospitalized patients and are both associated with increased all-cause and cardiovascular mortality. The presence of acute or chronic renal failure facilitates ...

Mar 11th, 2020 - This transcript has been edited for clarity. Hello. This is Ileana Piña. I'm a professor of medicine at Wayne State University, and this is my blog. We're going to talk about potassium. We have talked about potassium before. If you look at the lit...

Dec 17th, 2019 - Suboptimal dosing of renin-angiotensin-aldosterone system (RAAS) inhibitors to reduce the risk of hyperkalemia could increase the risk of major adverse cardiac events (MACE) and all-cause mortality in patients with chronic kidney disease (CKD) or.

Dec 14th, 2019 - Treatment with sodium zirconium cyclosilicate (SZC) led to lasting improvement of hyperkalemia, according to results from an 11-month open-label extension study of the HARMONIZE randomized clinical trial. SZC selectively binds potassium ions in th.

Nov 21st, 2019 - The hyperkalemia that commonly occurs in patients hospitalized for acute heart failure does not affect outcomes, but it can lead to treatment changes that can in turn raise the risk of mortality. That’s according to an analysis of data from 1,589.

Oct 22nd, 2019 - NEW YORK (Reuters Health) - Inpatient therapy for heart failure may induce iatrogenic hypokalemia or hyperkalemia, which in themselves appear not to be harmful - but related changes in medication might be, according to an international group of re...